{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-011712","form_type":"8-K","ticker":null,"cik":"0001279695","company_name":"UNIVERSAL BIOSENSORS INC","filed_at":"2024-04-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.692233+00:00","generated_at":"2026-06-03T23:51:15.920122+00:00","sec_items":["1.01","3.02","5.03","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Universal Biosensors launches A$10M underwritten entitlement offer at A$0.15/CDI with attaching options","bullets":["Fully underwritten pro-rata non-renounceable offer of 1 new CDI per 3.47 existing at A$0.15, plus 1 option per CDI (A$0.20 exercise, 3-year term).","Underwriter receives 13.85M options as fee; gross proceeds ~A$10M to fund growth, product development, operating losses, and Xprecia Prime sales after FDA approval.","Stockholders approved increase in authorized common shares from 300M to 750M at April 10 special meeting.","All four stockholder proposals passed: Underwriter Options, Placement CDIs, Placement Options, and Authorized Shares increase.","Offer restricted to Australia/New Zealand resident holders; U.S. persons and other ineligible holders excluded."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-011712","json":"https://secwatch.observer/filing/0001437749-24-011712.json","markdown":"https://secwatch.observer/filing/0001437749-24-011712.md","text":"https://secwatch.observer/filing/0001437749-24-011712.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/0001437749-24-011712-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/ubi20240411_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T23:51:15.920122+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"617aa0f40923809f1ee3cc69cfd3176d3b07e409","claim":"UNIVERSAL BIOSENSORS INC: Increased authorized shares of common stock from 300,000,000 to 750,000,000 (effective 2024-04-10).","evidence_excerpt":"the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation, as amended to date, to increase the number of authorized shares of the Company’s common stock from 300,000,000 shares to 750,000,000 shares.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/0001437749-24-011712-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-04-10"}],"fact_type":"governance_change"},{"claim_id":"36eb7b7a5db21e6c471e72408329e52e0bda4916","claim":"UNIVERSAL BIOSENSORS INC entered into Underwriting Agreement with an underwriter valued at approximately A$10 million (effective 2024-04-11).","evidence_excerpt":"On April 11, 2024, Universal Biosensors, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with an underwriter named in the Underwriting Agreement (the “Underwriter”), whereby the Company agreed to issue: (i) up to 66,666,667 shares of its common stock in the form of CHESS Depositary Interests (“CDIs”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/0001437749-24-011712-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"an underwriter"},{"label":"Value","value":"approximately A$10 million"},{"label":"Effective","value":"2024-04-11"}],"fact_type":"material_agreement"},{"claim_id":"119eb9099a7d3c68fb803a43afbe4d0f140b836a","claim":"UNIVERSAL BIOSENSORS INC shareholders approved Authorized Shares Proposal at the 2024-04-10 meeting.","evidence_excerpt":"Proposal 4 Authorized Shares Proposal 108,416,353 2,323,110 1,307,106 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/0001437749-24-011712-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-04-10"}],"fact_type":"shareholder_vote"},{"claim_id":"2fcf1c89ed5238b874b14784017ccd5e553a4883","claim":"UNIVERSAL BIOSENSORS INC shareholders approved Underwriter Options Proposal at the 2024-04-10 meeting.","evidence_excerpt":"Proposal 1 Underwriter Options Proposal 52,880,699 2,603,610 55,808,640 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/0001437749-24-011712-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-04-10"}],"fact_type":"shareholder_vote"},{"claim_id":"4dfa744d9300d4c18baaa3547210a600c3a88883","claim":"UNIVERSAL BIOSENSORS INC shareholders approved Placement CDIs Ratification Proposal at the 2024-04-10 meeting.","evidence_excerpt":"Proposal 2 Placement CDIs Ratification Proposal 103,092,909 7,643,449 1,310,211 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/0001437749-24-011712-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-04-10"}],"fact_type":"shareholder_vote"},{"claim_id":"e446174264506707133610c44aa9d22e897cc561","claim":"UNIVERSAL BIOSENSORS INC shareholders approved Placement Options Proposal at the 2024-04-10 meeting.","evidence_excerpt":"Proposal 3 Placement Options Proposal 102,831,014 7,908,449 1,307,106 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/0001437749-24-011712-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-04-10"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}